Skip to main content
TWST logo

Twist Bioscience Corporation

TWSTNASDAQHealthcareDiagnostics & Research

$144.49Today:- (-)1Y +369.89%

As of Oct 15, 2026 close

Market cap
$9.02B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$23.30$219.71
Volume (live)
-
Avg. volume (3M)
2.70M

Twist Bioscience (TWST) Balance Sheet

As of Sep 30, 2025 (end of fiscal 2025), Twist Bioscience reported total assets of $641.86M and total liabilities of $168.90M. Shareholders' equity was $472.96M, up 0.1% from $472.69M a year earlier. Total debt stood at $137.32M against $232.43M in cash and short-term investments, a net cash position of $95.11M. That puts debt-to-equity at 0.29, compared with 0.18 a year earlier.

Twist Bioscience Balance Sheet Analysis

Values in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Twist Bioscience Corporation (TWST) - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018Sep 2017
Current Assets
Cash and Cash Equivalents0.180.230.290.380.470.090.050.080.03
Short-Term Investments0.050.050.050.130.010.200.090.000.03
Cash & Short-Term Investments0.230.280.340.500.480.290.140.080.06
Accounts Receivable0.060.030.040.040.030.030.010.010.00
Inventory0.030.020.030.040.030.010.010.010.00
Other Current Assets0.020.010.010.010.010.010.000.010.00
Total Current Assets0.330.350.420.600.550.330.160.100.07
Non-Current Assets
Property, Plant & Equipment (Net)0.150.160.200.210.110.060.020.010.01
Long-Term Investments0.050.000.000.000.000.000.000.000.00
Goodwill0.080.090.090.090.020.000.000.000.00
Intangible Assets0.010.010.050.060.020.000.000.000.00
Other Non-Current Assets0.010.000.010.000.010.000.000.010.00
Total Non-Current Assets0.310.270.350.360.160.060.030.020.02
Total Assets0.640.610.780.960.700.400.190.120.09
Current Liabilities
Accounts Payable0.010.000.010.020.010.000.010.010.00
Short-Term Debt0.010.010.010.010.010.010.000.000.00
Current Portion of Long-Term Debt----0.00----
Accrued Liabilities0.020.020.010.010.03----
Deferred Revenue0.010.000.000.000.000.000.020.010.00
Other Current Liabilities0.060.000.000.010.030.020.020.010.01
Total Current Liabilities0.090.070.070.090.060.040.030.020.01
Non-Current Liabilities
Long-Term Debt0.120.070.080.080.050.030.000.010.01
Other Non-Current Liabilities-0.050.000.000.000.010.000.000.290.20
Total Non-Current Liabilities0.080.070.080.080.060.030.000.300.21
Total Liabilities0.170.140.150.170.120.060.030.320.22
Stockholders' Equity
Retained Earnings-1.32-1.24-1.03-0.83-0.61-0.46-0.32-0.21-0.14
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.000.000.00
Additional Paid-in Capital1.791.721.661.621.190.790.470.01-0.19
Shares Outstanding0.060.060.060.06-----
Total Stockholders' Equity0.470.470.620.790.580.340.15-0.20-0.13
Total Liabilities & Equity0.640.610.780.960.700.400.190.120.09

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Twist Bioscience Balance Sheet

How much debt does Twist Bioscience have?

Twist Bioscience had total debt of $137.32M as of Sep 30, 2025, against $232.43M in cash and short-term investments. Its debt-to-equity ratio was 0.29. Total debt was $85.03M a year earlier.

What are Twist Bioscience's total assets?

Twist Bioscience reported total assets of $641.86M as of Sep 30, 2025, up 4.5% from $614.32M a year earlier. Total liabilities were $168.90M.

What is Twist Bioscience's shareholders' equity?

Twist Bioscience's shareholders' equity was $472.96M as of Sep 30, 2025, or about $7.80 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition